title: Severe and prolonged jaundice in a lupus nephritis patient treated with cyclophosphamide.
authors.affiliation: Division of Nephrology and Dialysis, IRCCS, Ospedale Maggiore, Milano, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Moroni
authors.forename: M
authors.initials: M
authors.lastname: Maccario
authors.forename: S
authors.initials: S
authors.lastname: Fargion
authors.forename: C
authors.initials: C
authors.lastname: Ponticelli
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007565:Jaundice / Q000097:blood / Q000139:chemically induced*; D008181:Lupus Nephritis / Q000188:drug therapy*
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin